Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:PGEN News 14 November 2025

Precigen (PGEN) Soars as PAPZIMEOS Launch, Q3 2025 Earnings and Fresh Analyst Upgrades Ignite Investor Interest

Precigen (PGEN) Soars as PAPZIMEOS Launch, Q3 2025 Earnings and Fresh Analyst Upgrades Ignite Investor Interest

On 14 November 2025, Precigen, Inc. (NASDAQ: PGEN) is back in the spotlight. The gene‑therapy specialist’s stock is trading roughly 25–30% higher intraday around $4.90–$5.00, after closing at $3.86 on 13 November, on surging volume of nearly 11 million shares.StockAnalysis+1 The move caps a spectacular 12‑month run in which the stock has delivered well over 300% total return, powered by full FDA approval and U.S. launch of its PAPZIMEOS™ (zopapogene imadenovec‑drba) therapy for recurrent respiratory papillomatosis (RRP) and a wave of bullish post‑earnings commentary.Simply Wall St+1 Below is a breakdown of all the key Precigen news and market developments relevant
14 November 2025
·····

Stock Market Today

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

SSE share price near 2,510p as BoE rate-cut bets return; UK GDP and SSE updates ahead

7 February 2026
SSE shares closed Friday at 2,510p, up 1.2%, with about 6.6 million shares traded. The company’s transmission arm secured over £6.9 million in Ofgem innovation funding for four projects. Investors adjusted UK rate-cut bets after a split Bank of England decision. SSE maintained 2025/26 earnings guidance and reported a 7% rise in renewables output.
Go toTop